Skip to main content

Advertisement

SpringerLink
Log in

Multimodal treatment of desmoid tumours: the significance of local control

  • Research Articles
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

Abstract

Introduction

Desmoid tumours are a rare group of tumours arising in the deep musculoaponeurotic structures and although they have no metastatic potential they can be locally aggressive with relapse rates of between 23–40%. Three sub-sites are reported: extra-abdominal, abdominal wall and intra-abdominal. The purpose of this study was to analyze patients with these tumours treated and followed at our institution and to determine factors influencing disease free survival.

Material and methods

We conducted a retrospective study of 20 patients treated between 1997 and 2009. Data was compiled to include age, gender, surgical history, familial adenomatous polyposis (FAP), contraceptives, tumour site, first-line treatment, positive margins and adjuvant radiotherapy. A descriptive and survival statistical analysis was also performed.

Results

Most patients were women, with a median age of 36 years, with abdominal wall involvement and treated with complete surgery without adjuvant radiotherapy. With a median follow-up of 35 months (range 0–188), local control at 5 years for any kind of treatment was 80%. Overall survival (OS) and 5-year progression-free survival (PFS) were 100% and 86%, respectively.

Conclusion

Desmoid tumours are group of rare tumours. Although complete surgical resection remains the cornerstone of treatment for resectable lesions, there is still substantial risk of recurrence. Our outcomes are comparable to those reported in the few series published to date.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Spear MA, Jennings LC, Mankin HJ et al (1998) Individualizing management of aggressive fibromatoses. Int J Radiat Oncol Biol Phys 40:637–645

    Article  PubMed  CAS  Google Scholar 

  2. Merchant NB, Lewis JJ, Woodruff JM et al (1999) Extremity and trunk desmoid tumors: a multifactorial analysis of outcome. Cancer 86:2045–2052

    Article  PubMed  CAS  Google Scholar 

  3. Lev D, Kotilingam D, Wei C et al (2007) Optimizing treatment of desmoid tumors. J Clin Oncol 25:1785–1791

    Article  PubMed  Google Scholar 

  4. Wong SL (2008) Diagnosis and management of desmoid tumors and fibrosarcoma J Surg Oncol 97:554–558

    Article  PubMed  Google Scholar 

  5. Lewis JJ, Boland PJ, Leung DHY et al (1999) The enigma of desmoid tumors. Ann Surg 229:866–872; discussion 872–873

    Article  PubMed  CAS  Google Scholar 

  6. Sturt NJ, Gallagher MC, Bassett P et al (2004) Evidence for genetic predisposition to desmoid tumours in familial adenomatous polyposis independent of the germline APC mutation. Gut 53:1832–1836

    Article  PubMed  CAS  Google Scholar 

  7. Tejpar S, Nollet F, Li C et al (1999) Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene 18:6615–6620

    Article  PubMed  CAS  Google Scholar 

  8. Dinauer PA, Brixey CJ, Moncur JT et al (2007) Pathologic and MR imaging features of benign fibrous soft-tissue tumors in adults. Radiographics 27:173–187

    Article  PubMed  Google Scholar 

  9. Posner MC, Shiu MH, Newsome JL et al (1989) The desmoid tumor. Not a benign disease. Arch Surg 124:191–196

    CAS  Google Scholar 

  10. Ballo MT, Zagars GK, Pollack A (1998) Radiation therapy in the management of desmoid tumors. Int J Radiat Oncol Biol Phys 42:1007–1014

    Article  PubMed  CAS  Google Scholar 

  11. Gronchi A, Casali PG, Mariani L et al (2003) Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution. J Clin Oncol 21:1390–1397

    Article  PubMed  CAS  Google Scholar 

  12. Jelinek JA, Stelzer KJ, Conrad E et al (2001) The efficacy of radiotherapy as postoperative treatment for desmoid tumors. Int J Radiat Oncol Biol Phys 50:121–125

    Article  PubMed  CAS  Google Scholar 

  13. Zlotecki RA, Scarborough MT, Morris CG et al (2002) External beam radiotherapy for primary and adjuvant management of aggressive fibromatosis. Int J Radiat Oncol Biol Phys 54:177–181

    PubMed  Google Scholar 

  14. Micke O, Seegenschmiedt MH (2005) Radiation therapy for aggressive fibromatosis (desmoid tumors): results of a national Patterns of Care Study. Int J Radiat Oncol Biol Phys 61:882–891

    Article  PubMed  Google Scholar 

  15. McAdam WA, Goligher JC (1970) The occurrence of desmoids in patients with familial polyposis coli. Br J Surg 57:618–631

    Article  PubMed  CAS  Google Scholar 

  16. Reitamo JJ, Scheinin TM, Hayry P (1986) The desmoid syndrome. New aspects in the cause, pathogenesis and treatment of the desmoid tumor. Am J Surg 151:230–237

    CAS  Google Scholar 

  17. Rock MG, Pritchard DJ, Reiman HM et al (1984) Extra-abdominal desmoid tumors. J Bone Joint Surg Am 66:1369–1374

    PubMed  CAS  Google Scholar 

  18. Procter H, Singh L, Baum M, Brinkley D (1987) Response of multicentric desmoid tumours to tamoxifen. Br J Surg 74:401

    Article  PubMed  CAS  Google Scholar 

  19. Brooks MD, Ebbs SR, Colletta AA, Baum M (1992) Desmoid tumours treated with triphenylethylenes. Eur J Cancer 28A:1014–1018

    Article  PubMed  CAS  Google Scholar 

  20. Klein WA, Miller HH, Anderson M, DeCosse JJ (1987) The use of indomethacin, sulindac, and tamoxifen for the treatment of desmoid tumors associated with familial polyposis. Cancer 60:2863–2868

    Article  PubMed  CAS  Google Scholar 

  21. Izes JK, Zinman LN, Larsen CR (1996) Regression of large pelvic desmoid tumor by tamoxifen and sulindac. Urology 47:756–759

    Article  PubMed  CAS  Google Scholar 

  22. Lackner H, Urban C, Kerbl R et al (1997) Noncytotoxic drug therapy in children with unresectable desmoid tumors. Cancer 80:334–340

    Article  PubMed  CAS  Google Scholar 

  23. Tsukada K, Church JM, Jagelman DG et al (1992) Noncytotoxic drug therapy for intra-abdominal desmoid tumor in patients with familial adenomatous polyposis. Dis Colon Rectum 35:29–33

    Article  PubMed  CAS  Google Scholar 

  24. Pilz T, Pilgrim TB, Bisogno G et al (1999) [Chemotherapy in fibromatoses of childhood and adolescence: results from the Cooperative soft tissue sarcoma study (CWS) and the Italian Cooperative study group (ICG-AIEOP)]. Klin Padiatr 211:291–295

    Article  PubMed  CAS  Google Scholar 

  25. Weiss AJ, Lackman RD (1989) Low-dose chemotherapy of desmoid tumors. Cancer 64:1192–1194

    Article  PubMed  CAS  Google Scholar 

  26. Azzarelli A, Gronchi A, Bertulli R et al (2001) Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis. Cancer 92:1259–1264

    Article  PubMed  CAS  Google Scholar 

  27. Mace J, Sybil Biermann J, Sondak V et al (2002) Response of extraabdominal desmoid tumors to therapy with imatinib mesylate. Cancer 95:2373–2379

    Article  PubMed  CAS  Google Scholar 

  28. Heinrich MC, McArthur GA, Demetri GD et al (2006) Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor). J Clin Oncol 24:1195–1203

    Article  PubMed  CAS  Google Scholar 

  29. Heinrich MC, Joensuu H, Demetri GD et al (2008) Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib-sensitive tyrosine kinases. Clin Cancer Res 14:2717–2725

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Oncology, Hospital Clínico Universitario Virgen de la Victoria, C/ Boulevard Luis Pasteur, s/n, ES-29010, Málaga, Spain

    Bella Pajares, Esperanza Torres, Begoña Jiménez, Isabel Sevilla, José Manuel Trigo & Emilio Alba

  2. Department of Radiology, Hospital Clínico Universitario Virgen de la Victoria, Málaga, Spain

    Ana Rodríguez

  3. Department of Radiation Oncology, Hospital Clínico Universitario Virgen de la Victoria, Málaga, Spain

    José Manuel Rico

Authors
  1. Bella Pajares
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Esperanza Torres
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Begoña Jiménez
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Isabel Sevilla
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ana Rodríguez
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. José Manuel Rico
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. José Manuel Trigo
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Emilio Alba
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bella Pajares.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pajares, B., Torres, E., Jiménez, B. et al. Multimodal treatment of desmoid tumours: the significance of local control. Clin Transl Oncol 13, 189–193 (2011). https://doi.org/10.1007/s12094-011-0639-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-011-0639-4

Keywords

Search

Navigation